October 17, 2017
Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm
Media
October 16, 2017
Aprea Therapeutics Announces First Patients Enrolled in Phase Ib/II Clinical Study of APR-246 for the Treatment of Esophageal Cancer
October 16, 2017
Nexstim Plc is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US
October 16, 2017
GenSight Biologics to Present Data on GS010 and GS030 at the 2017 Congress of the European Society of Gene & Cell Therapy
October 12, 2017
Change in Nexstim Plc’s Management Team
October 12, 2017
Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
October 06, 2017
Phase 2 Clinical Trial Data for WTX101 Published in The Lancet Gastroenterology & Hepatology
October 06, 2017
Strongbridge Biopharma plc Announces Closing of Public Offering of Ordinary Shares
October 04, 2017
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
October 04, 2017
GenSight Biologics to Attend Chardan Gene Therapy Conference